Medicamen Biotech

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue43.5147.5447.4462.3948.76
Expenses41.3844.8645.3357.3246.19
EBITDA5.085.534.917.175.19
Operating Profit3.283.673.085.443.40
Profit Before Tax2.132.682.115.062.58
Net Profit1.602.111.634.451.85
Financial Ratios
Operating Profit Margin11.83%11.72%10.47%11.84%10.84%
Net Profit Margin5.00%5.66%4.67%6.36%4.43%
Earning Per Share (Diluted)1.181.561.213.281.36
Dividends Per Share0.000.000.000.000.00